NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones
NeOnc Technologies, a clinical-stage biotech firm specializing in central nervous system cancers, has seen increased interest from Wall Street analysts and institutional investors as it approaches key clinical milestones for its brain cancer therapies. The company's CEO has made significant insider stock purchases, signaling confidence in upcoming …